Zomedica Corp., a veterinary health company, has announced a strategic partnership with VerticalVet, a prominent Group Purchasing Organization in the veterinary industry. This two-year agreement positions Zomedica as a preferred provider of advanced veterinary solutions to VerticalVet's network, which includes over 2,600 independent veterinary practices across the United States. The collaboration will provide VerticalVet members with access to Zomedica's innovative technologies, such as the PulseVet® shock wave therapy system, the VETGuardian® remote monitoring platform, Assisi® tPEMF therapy devices, and Vetigel® hemostatic gel. These solutions aim to enhance clinical excellence and operational efficiency in veterinary care. Mark Wainscott, President of VerticalVet, highlighted the partnership's potential to elevate clinical outcomes and support independent practices in delivering superior patient care.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1062405) on August 19, 2025, and is solely responsible for the information contained therein.
Comments